Autres langues HORIBA, Ltd.

Actions

6856

JP3853000002

Temps Différé Japan Exchange Autres places de cotation 08:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
14 785 ^JPY	+1,90 %		+3,14 %	+34,04 %

29/02	HORIBA, Ltd. donne des prévisions de résultats pour l'année 2028	CI
21/02	HORIBA, LTD. : Jefferies & Co. confirme sa recommandation neutre	ZM

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Tranche Update on HORIBA, Ltd.'s Equity Buyback Plan announced on February 14, 2024.	24/04
HORIBA, Ltd.'s Equity Buyback announced on February 14, 2024, has closed with 334,500 shares, representing 0.79% for ¥4,998.65 million.	23/04
Tranche Update on HORIBA, Ltd.'s Equity Buyback Plan announced on February 14, 2024.	04/04
HORIBA : Position and Policy Regarding Reduction of Minimum Stock Trading Unit of the…	29/03
HORIBA : Notice of resolutions of the 86th Ordinary General Meeting of Shareholders	25/03
HORIBA, Ltd. Provides Earnings Guidance for the Year 2028	29/02
Japanese Shares Track Other Asia Stocks Lower Despite China's Rate Cut	20/02
Horiba Starts 5 Billion Yen Share Buyback Program	20/02
Horiba's 2023 Attributable Net Income, Net Sales Rise on Strong Automotive Business	20/02
HORIBA, Ltd. announces an Equity Buyback for 530,000 shares, representing 1.25% for ¥5,000 million.	14/02
Horiba, Ltd. Announces Year End Dividend for 2023 , Payable on March 4, 2024	14/02
HORIBA, Ltd. Provides Dividend Guidance for the Year Ending December 31, 2024	14/02
Horiba, Ltd. Provides Dividend Guidance for the Second Quarter End of Year Ending December 31, 2024	14/02
HORIBA, Ltd. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending December 31, 2024	14/02
HORIBA, Ltd. authorizes a Buyback Plan.	14/02
HORIBA : Medical launches next generation HELO fully automated modular hematology solution	03/01
HORIBA : Acute Leukemia - HORIBA Medical QSP Newsletter #42	26/12
HORIBA : Pyropoikilocytosis - Yumizen Hematology Clinical Cases "Chase the Case" #27	18/12
HORIBA : Presentation material (Q3 2023)	24/11
Horiba's Nine-Month Attributable Net Income Grows, Boosted by Automotive Business	16/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues HORIBA, Ltd.

Actions

6856

JP3853000002

Autres langues

Filtres